BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1303 related articles for article (PubMed ID: 11244034)

  • 1. Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?
    Feldmann M; Maini RN
    Annu Rev Immunol; 2001; 19():163-96. PubMed ID: 11244034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological insights from clinical trials with anti-TNF therapy.
    Feldmann M; Charles P; Taylor P; Maini RN
    Springer Semin Immunopathol; 1998; 20(1-2):211-28. PubMed ID: 9836378
    [No Abstract]   [Full Text] [Related]  

  • 3. [Role of anti-TNF therapy in rheumatoid arthritis].
    Meyer O
    Presse Med; 2000 Mar; 29(9):463-8. PubMed ID: 10745935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TNF blockade in the treatment of rheumatoid arthritis: infliximab versus etanercept.
    Mikuls TR; Moreland LW
    Expert Opin Pharmacother; 2001 Jan; 2(1):75-84. PubMed ID: 11336570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Value of anti-TNF-alpha molecules in inflammatory and infectious diseases].
    Fautrel B; Cherin P
    Rev Med Interne; 2000 Oct; 21(10):872-88. PubMed ID: 11075396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [New drugs and treatment strategies for rheumatoid arthritis].
    Fantini F
    Recenti Prog Med; 2003 Sep; 94(9):361-79. PubMed ID: 12942798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of rheumatoid arthritis by inhibition of tumor necrosis factor with infliximab or etanercept].
    Tijhuis GJ; van de Putte LB; Breedveld FC
    Ned Tijdschr Geneeskd; 2001 Sep; 145(39):1880-5. PubMed ID: 11605312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumour necrosis factor-alpha blockade: a new era for effective management of rheumatoid arthritis.
    Hamilton K; Clair EW
    Expert Opin Pharmacother; 2000 Jul; 1(5):1041-52. PubMed ID: 11249494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TNF alpha inhibitors in the treatment of psoriasis and psoriatic arthritis.
    Tobin AM; Kirby B
    BioDrugs; 2005; 19(1):47-57. PubMed ID: 15691217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New indications for treatment of chronic inflammation by TNF-alpha blockade.
    Reimold AM
    Am J Med Sci; 2003 Feb; 325(2):75-92. PubMed ID: 12589232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanisms of action of anti-TNF-α agents - Comparison among therapeutic TNF-α antagonists.
    Mitoma H; Horiuchi T; Tsukamoto H; Ueda N
    Cytokine; 2018 Jan; 101():56-63. PubMed ID: 27567553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Paradigm shift in the treatment of rheumatoid arthritis by biologics].
    Tanaka Y
    Rinsho Byori; 2008 Apr; 56(4):309-15. PubMed ID: 18516965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor necrosis factor-alpha blockade: a novel therapy for rheumatic disease.
    Shanahan JC; St Clair W
    Clin Immunol; 2002 Jun; 103(3 Pt 1):231-42. PubMed ID: 12173297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokines in rheumatoid arthritis: trials and tribulations.
    Carteron NL
    Mol Med Today; 2000 Aug; 6(8):315-23. PubMed ID: 10904249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [TNF inhibitors: a new therapeutic perspective in chronic inflammatory diseases in rheumatology?].
    Fenner H
    Z Rheumatol; 1995; 54(3):158-64. PubMed ID: 7660686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid profile of rheumatoid arthritis patients treated with anti-tumor necrosis factor-alpha drugs changes according to disease activity and predicts clinical response.
    Cacciapaglia F; Anelli MG; Rinaldi A; Serafino L; Covelli M; Scioscia C; Iannone F; Lapadula G
    Drug Dev Res; 2014 Nov; 75 Suppl 1():S77-80. PubMed ID: 25381986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [62nd Congress of the American College of Rheumatology, San Diego, 8-12 November 1998].
    Cherin P
    Rev Med Interne; 1999 Apr; 20(4):311-7. PubMed ID: 10327473
    [No Abstract]   [Full Text] [Related]  

  • 18. Tumor necrosis factor inactivation in the management of rheumatoid arthritis.
    Baumgartner SW
    South Med J; 2000 Aug; 93(8):753-9. PubMed ID: 10963503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current and future use of anti-TNF agents in the treatment of autoimmune, inflammatory disorders.
    Calamia KT
    Adv Exp Med Biol; 2003; 528():545-9. PubMed ID: 12918761
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of rheumatoid arthritis by TNF-blocking agents.
    Graninger W; Smolen J
    Int Arch Allergy Immunol; 2002 Jan; 127(1):10-4. PubMed ID: 11893849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 66.